Neuroscientists revealed Integrated multimodal cell atlas of Alzheimer’s disease
On Oct, 14, 2024, a team of researchers from the Allen Institute of Brain Science and the University…
RedHill Biopharma Secured U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment
On Oct. 14, 2024, RedHill Biopharma announced that the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA)…
WHO reported Increase in Rwanda Marburg virus disease incidence
On Oct. 11, 2024, the World Health Organization (WHO) reported that a total of 58 cases of Marburg…
KAIST Changes the Paradigm of Drug Discovery with World’s First Atomic Editing
On Oct. 11, 2024, scientists at the Korea Advanced Institute of Science and Technology (KAIST) announced they had…
Suspected Outbreak of Trichinellosis in North Carolina Associated with Undercooked Bear Meat
On Oct. 10, 2024, the U.S. Centers for Disease Control and Prevention announced that a 2023 presumed outbreak…
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
On Oct. 10, 2024, Genentech announced today that the U.S. Food and Drug Administration (FDA) approved ItovebiTM (inavolisib),…
Common arm positions can substantially overestimate blood pressure readings, Johns Hopkins study finds
On Oct. 9, 2024, a study led by Johns Hopkins Medicine researchers concluded that commonly used ways of…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Neurology | NIH | Non-Profit Research | Therapeutics | Vaccine
Study Found Persistent Infection Could Explain Long COVID in Some People
On Oct. 9, 2024, researchers from Brigham and Women’s Hospital found that people with wide-ranging long COVID symptoms…
Brain’s waste-clearance pathways revealed for the first time
On Oct. 9, 2024, scientists from Oregon Health & Science University (OHSU) released a study that used imaging…
Artificial Intelligence | Biotechnology | Chemical | Genomics | Medicine | Non-Profit Research | Therapeutics
Nobel Prize in Chemistry awarded to David Baker “for computational protein design”; Demis Hassabis and John M. Jumper “for protein structure prediction”
On Oct. 9, 2024, the Nobel Foundation awarded the Nobel Prize in Chemistry: one half to David Baker,…
City of Seattle became first in nation with fire department EMTs administering buprenorphine medication in the field
Oct. 9, 2024, the Seattle Fire Department (SFD) expanded its Buprenorphine Pilot Program and Seattle became the first…
Special ‘skinny genes’ linked to weight loss
On Oct. 8, 2024, a team of University of Essex researchers found that the secret to losing weight…
Scientists develop a new method to study gene function in cells and tissue
On Oct. 7, 2024, Columbia University researchers announced they had developed a new optical pooled screening approach called…
Nobel Prize in Physiology or Medicine awarded to Victor Ambros and Gary Ruvkun
On Oct. 7, 2024, The Nobel Foundation announced that Victor Ambros from Harvard University and Gary Ruvkun from…
San Diego County Reported First Locally Acquired Dengue Case
On Oct. 6, 2024, San Diego County officials announced they were investigating the first ever case of locally…
COVID-19 hospitalization remained higher among older adults
On Oct. 4, 2024, the Centers for Disease Control and Prevention (CDC) published data that showed older adults…
Biotechnology | Diagnostics | Infectious Disease | Medicine | Therapeutics | Vaccine | WHO
WHO launches global strategic plan to fight rising dengue and other Aedes-borne arboviral diseases
On Oct. 3, 2024,the World Health Organization (WHO) launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP)…
Nebraska Department of Health Reported Increase in Tularemia Cases
On Oct. 3, 2024, the Nebraska Department of Health and Human Services announced that 18 cases of tularemia…
MERS coronavirus case reported in Saudi Arabia
On Oct. 2, 2024, the World Health Organization (WHO) announced it had been notified of one human case…
Lilly announced $4.5 billion investment in the Lilly Medicine Foundry – to drive innovation in drug production and medicines for clinical trials
On Oct. 2, 2024, Eli Lilly and Company announced a $4.5 billion investment to create the Lilly Medicine…
Breast Cancer Mortality Continues Three Decade Decline, but Steeper Increases in Incidence for Women <50
On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…
Mental and health problems concentrated in 20% of the population
On Oct. 1, 2024, a study by the University of Amsterdam and the Trimbos Institute showed that 20%…
Biotechnology | Diagnostics | Environmental | Genomics | Infectious Disease | Medical Device | Nanotechnology | Oncology | Therapeutics | U.S. Congress
Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity
On Oct. 1, 2024, the National Academy of Medicine (NAM) announced a study showing that although the U.S….
Risk of Dementia Diagnosis After Injurious Falls in Older Adults
On Sept. 30, 2024, a research team reported that emerging evidence suggested that mild cognitive impairment, which is…
Biotechnology | Disease | FDA | Neurology | Therapeutics
Amneal Launched CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease
On Sept. 30, 2024, Amneal Pharmaceuticals announced that it had launched CREXONT ® (carbidopa and levodopa) extended-release capsules…
Brain Scans revealed changes from Long COVID Fatigue
On Sept. 27, 2024, a study that evaluated the structural and functional connectivity correlates of fatigue in post-COVID…
New mutation linked to early-onset Parkinsonism
On Sept. 26. 2024, a team of scientists led by Prof. Patrik Verstreken at the VIB-KU Leuven Center…
Stem cells reverse woman’s diabetes — a world first
On Sept. 26, 2024, a team of scientists in Peking University in Beijing, China announced that a 25-year-old…
Biotechnology | Diagnostics | FDA | Neurology | Therapeutics
FDA Approved Drug with New Mechanism of Action for Treatment of Schizophrenia
On Sept. 26, 2024, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers Squibb’s Cobenfy (xanomeline and trospium…
Superbugs could jeopardise food security for over two billion people and increase annual health care costs by U.S. $159 billion annually by 2050, finds most extensive modelling to date
On Sept. 25, 2024, drug-resistant pathogens could jeopardise the food supply of over two billion people and increase…